• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMIN, INTRAVASCULAR.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CAREFUSION ALARIS PUMP MODULE ADMINISTRATION SET; SET, ADMIN, INTRAVASCULAR. Back to Search Results
Model Number 2420-0007
Device Problems Fluid/Blood Leak (1250); Material Split, Cut or Torn (4008)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/10/2020
Event Type  malfunction  
Manufacturer Narrative
Concomitant medical products-100ml baxter bag, lot: us004093, exp: oct20, 0.9% sodium chloride injection.The affected product has been received and the investigation is pending.A follow up report will be submitted once the failure investigation has been completed.
 
Event Description
It was reported that the iv tubing set leaked during the final infusion of ceftriaxone, total bag was 150ml.At the completion of the infusion there was a small puddle next to the patient and it was discovered that there was a hole in the tubing set.The patient received reduced dosage of medication, but was not impacted.
 
Manufacturer Narrative
Additional information added: section; b.5.(patient/event information clarified/detailed), d.11, and h.6.(device code).The customer¿s report that the tubing set leaked was confirmed based on visual inspection.There was a protrusion along the tubing above the bottom smartsite valve component marked between tape strips.There was a hole along the protrusion.Functional testing performed observed fluid to leak from the hole.The cause of the leak was due to the damaged tubing.Two tape strips were affixed along the tubing between the lower fitment and bottom smartsite valve components.The set sample was visually inspected for kinks, holes/tears in the tubing or damages to the components.Although damage was observed, the set was reprimed.Fluid leaked from the hole.No other leak or issue was observed.The cause of the leak was due to a damaged tubing.The root cause of the damage was not identified.
 
Event Description
It was reported that the iv tubing set leaked during the final infusion of ceftriaxone, total bag was 150ml.At the completion of the infusion there was a small puddle next to the patient and it was discovered that there was a hole in the tubing set.Although it was noted that the patient received reduced dosage of medication, it was also confirmed during follow up, that there was no patient harm or impact as a result of this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ALARIS PUMP MODULE ADMINISTRATION SET
Type of Device
SET, ADMIN, INTRAVASCULAR.
Manufacturer (Section D)
CAREFUSION
10020 pacific mesa blvd
san diego CA 92121 4386
MDR Report Key9769339
MDR Text Key189230829
Report Number9616066-2020-00612
Device Sequence Number1
Product Code FPA
UDI-Device Identifier07613203021012
UDI-Public7613203021012
Combination Product (y/n)N
PMA/PMN Number
K944320
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number2420-0007
Device Catalogue Number2420-0007
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/17/2020
Initial Date Manufacturer Received Not provided
Initial Date FDA Received02/28/2020
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/02/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
8015, 8100; THERAPY DATE (B)(6) 2020
-
-